VBLT 株式概要
Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States.
Vascular Biogenics Ltd. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$0.16 |
| 52週高値 | US$0.32 |
| 52週安値 | US$0.10 |
| ベータ | 0.71 |
| 11ヶ月の変化 | -33.33% |
| 3ヶ月変化 | -45.07% |
| 1年変化 | 9.17% |
| 33年間の変化 | -86.55% |
| 5年間の変化 | -88.53% |
| IPOからの変化 | -97.33% |
最新ニュース
Recent updates
VBL Therapeutics receives non-compliance letter from Nasdaq
Sep 01VBL Therapeutics GAAP EPS of -$0.12
Aug 15VBL Therapeutics' late-stage trial for ovarian cancer treatment does not meet main goals
Jul 19Here's Why We're Watching Vascular Biogenics' (NASDAQ:VBLT) Cash Burn Situation
May 18
Vascular Biogenics Trial Nears Full Enrollment, Price Could Jump
Sep 03How Much Are Vascular Biogenics Ltd. (NASDAQ:VBLT) Insiders Spending On Buying Shares?
Mar 17How Much Of Vascular Biogenics Ltd. (NASDAQ:VBLT) Do Insiders Own?
Jan 28VBL Therapeutics expands the ovarian cancer trial in Europe
Dec 29Is Vascular Biogenics (NASDAQ:VBLT) In A Good Position To Deliver On Growth Plans?
Dec 24
Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Have Been Cutting Their Estimates
Nov 19VBL Therapeutics EPS beats by $0.01, misses on revenue
Nov 16株主還元
| VBLT | US Biotechs | US 市場 | |
|---|---|---|---|
| 7D | -34.5% | -0.7% | -1.6% |
| 1Y | 9.2% | 19.8% | 30.8% |
業界別リターン: VBLT exceeded the US Biotechs industry which returned -4.2% over the past year.
リターン対市場: VBLT underperformed the US Market which returned 14.1% over the past year.
価格変動
| VBLT volatility | |
|---|---|
| VBLT Average Weekly Movement | 13.5% |
| Biotechs Industry Average Movement | 9.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
安定した株価: VBLT's share price has been volatile over the past 3 months.
時間の経過による変動: VBLT's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2000 | 7 | Dror Harats | www.vblrx.com |
Vascular Biogenics Ltd. 基礎のまとめ
| VBLT 基礎統計学 | |
|---|---|
| 時価総額 | US$12.11m |
| 収益（TTM） | -US$15.95m |
| 売上高(TTM) | US$481.00k |
25.2x
P/Sレシオ-0.8x
PER（株価収益率VBLT は割高か？
公正価値と評価分析を参照収益と収入
| VBLT 損益計算書（TTM） | |
|---|---|
| 収益 | US$481.00k |
| 売上原価 | US$17.00k |
| 売上総利益 | US$464.00k |
| その他の費用 | US$16.42m |
| 収益 | -US$15.95m |
直近の収益報告
Jun 30, 2023
次回決算日
該当なし
| 一株当たり利益（EPS） | -0.21 |
| グロス・マージン | 96.47% |
| 純利益率 | -3,317.05% |
| 有利子負債／自己資本比率 | 0% |
VBLT の長期的なパフォーマンスは？
過去の実績と比較を見る